Wiesława Niklińska

1.6k total citations
77 papers, 1.3k citations indexed

About

Wiesława Niklińska is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Wiesława Niklińska has authored 77 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 29 papers in Pulmonary and Respiratory Medicine and 27 papers in Oncology. Recurrent topics in Wiesława Niklińska's work include Lung Cancer Treatments and Mutations (18 papers), Cancer-related Molecular Pathways (13 papers) and Cancer Genomics and Diagnostics (8 papers). Wiesława Niklińska is often cited by papers focused on Lung Cancer Treatments and Mutations (18 papers), Cancer-related Molecular Pathways (13 papers) and Cancer Genomics and Diagnostics (8 papers). Wiesława Niklińska collaborates with scholars based in Poland, Belgium and United States. Wiesława Niklińska's co-authors include L Chyczewski, Jacek Nikliński, Wojciech Naumnik, E Chyczewska, J Laudański, Mirosław Kozłowski, Oksana Kowalczuk, Tomasz Burzykowski, Anetta Sulewska and S Terlikowski and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Wiesława Niklińska

76 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wiesława Niklińska Poland 23 577 393 333 271 137 77 1.3k
Yan Zhu China 21 518 0.9× 399 1.0× 243 0.7× 347 1.3× 205 1.5× 69 1.3k
David H. Moore United States 15 647 1.1× 411 1.0× 261 0.8× 237 0.9× 156 1.1× 34 1.3k
Krzysztof Goryca Poland 19 762 1.3× 283 0.7× 217 0.7× 326 1.2× 142 1.0× 69 1.3k
J.M. Foidart Belgium 16 736 1.3× 583 1.5× 249 0.7× 753 2.8× 98 0.7× 49 2.1k
Wenting Xu China 18 872 1.5× 424 1.1× 206 0.6× 412 1.5× 162 1.2× 46 1.6k
Ke Li China 20 460 0.8× 370 0.9× 164 0.5× 242 0.9× 145 1.1× 78 1.3k
Valentina Pozzi Italy 26 772 1.3× 392 1.0× 181 0.5× 165 0.6× 89 0.6× 50 1.4k
Chunxiang Li China 18 524 0.9× 327 0.8× 261 0.8× 232 0.9× 98 0.7× 83 1.3k
Lijing Wang China 20 668 1.2× 178 0.5× 126 0.4× 299 1.1× 89 0.6× 66 1.2k

Countries citing papers authored by Wiesława Niklińska

Since Specialization
Citations

This map shows the geographic impact of Wiesława Niklińska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wiesława Niklińska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wiesława Niklińska more than expected).

Fields of papers citing papers by Wiesława Niklińska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wiesława Niklińska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wiesława Niklińska. The network helps show where Wiesława Niklińska may publish in the future.

Co-authorship network of co-authors of Wiesława Niklińska

This figure shows the co-authorship network connecting the top 25 collaborators of Wiesława Niklińska. A scholar is included among the top collaborators of Wiesława Niklińska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wiesława Niklińska. Wiesława Niklińska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gagat, Maciej, et al.. (2024). Cyclin-Dependent Kinase Inhibitors in the Rare Subtypes of Melanoma Therapy. Molecules. 29(22). 5239–5239. 3 indexed citations
2.
Bossowski, Artur, et al.. (2016). Identification of Zinc Transporter ZnT8 in Thyroid Tissues from Children and Adolescents with Thyroid Nodular Hyperplasia. 86. 1 indexed citations
3.
Naumnik, Wojciech, Beata Naumnik, Wiesława Niklińska, Maria Ossolińska, & E Chyczewska. (2016). Osteoprotegerin/sRANKL Signaling System in Pulmonary Sarcoidosis: A Bronchoalveolar Lavage Study. Advances in experimental medicine and biology. 944. 1–7. 3 indexed citations
4.
Pancewicz, Joanna, Andrzej Eljaszewicz, Oksana Kowalczuk, et al.. (2016). Prognostic significance of Notch ligands in patients with non-small cell lung cancer. Oncology Letters. 13(1). 506–510. 10 indexed citations
5.
Charkiewicz, Radosław, Lothar R. Pilz, Anetta Sulewska, et al.. (2015). Validation for histology‐driven diagnosis in non‐small cell lung cancer using hsa‐miR‐205 and hsa‐miR‐21 expression by two different normalization strategies. International Journal of Cancer. 138(3). 689–697. 16 indexed citations
6.
Kowalczuk, Oksana, et al.. (2014). Increased MET Gene Copy Number but Not mRNA Level Predicts Postoperative Recurrence in Patients with Non–Small Cell Lung Cancer. Translational Oncology. 7(5). 605–612. 6 indexed citations
7.
8.
Milewski, Robert, et al.. (2009). Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC).. SHILAP Revista de lepidopterología. 3 indexed citations
9.
Chyczewska, E, Maria Ossolińska, Wiesława Niklińska, & Wojciech Naumnik. (2009). Serum cathepsin K and cystatin C concentration in patients with advanced non-small-cell lung cancer during chemotherapy.. SHILAP Revista de lepidopterología. 1 indexed citations
10.
Terlikowski, S, Andrzej Mazurek, Oksana Kowalczuk, et al.. (2009). Mutations of the KRAS oncogene in endometrial hyperplasia and carcinoma.. SHILAP Revista de lepidopterología. 4 indexed citations
11.
Dobrzycka, Bożena, S Terlikowski, Oksana Kowalczuk, et al.. (2009). Mutations in the KRAS gene in ovarian tumors.. Folia Histochemica et Cytobiologica. 47(2). 221–4. 17 indexed citations
12.
Chyczewski, L, Jacek Nikliński, J Laudański, et al.. (2008). Immunoexpression of P16INK4a, Rb and TP53 proteins in bronchiolar columnar cell dysplasia (BCCD) in lungs resected due to primary non-small cell lung cancer.. SHILAP Revista de lepidopterología. 1 indexed citations
13.
Sulewska, Anetta, Wiesława Niklińska, Wojciech Naumnik, et al.. (2008). Immunoexpression of P16INK4a, Rb and TP53 proteins in bronchiolar columnar cell dysplasia (BCCD) in lungs resected due to primary non-small cell lung cancer.. Folia Histochemica et Cytobiologica. 46(1). 89–96. 3 indexed citations
14.
Kozłowski, Mirosław, Oksana Kowalczuk, Anetta Sulewska, et al.. (2007). Serum soluble Fas ligand (sFasL) in patients with primary squamous cell carcinoma of the esophagus.. SHILAP Revista de lepidopterología. 45(3). 199–204. 19 indexed citations
15.
Pierzyński, Piotr, et al.. (2002). Angiogenesis and Bcl-2 protein expression in patients with endometrial carcinoma.. PubMed. 49(3). 149–54. 4 indexed citations
16.
Nikliński, Jacek, L Chyczewski, & Wiesława Niklińska. (2001). p53 and p16 alterations in lung cancer. 39(1). 1 indexed citations
17.
Niklińska, Wiesława, L Chyczewski, J Laudański, E Chyczewska, & Jacek Nikliński. (2001). Detection of p16 abnormalities in early-stage non-small cell lung cancer.. PubMed. 39 Suppl 2. 30–2. 6 indexed citations
18.
Chyczewski, L, et al.. (2001). The impact of immune responses on lung cancer and the development of new treatment modalities. Lung Cancer. 34. S71–S77. 10 indexed citations
19.
Chyczewski, L, et al.. (1999). p53 protein expression in resected invasive esophageal cancer.. PubMed. 46(3). 150–5. 3 indexed citations
20.
Nikliński, Jacek, Tomasz Burzykowski, Wiesława Niklińska, et al.. (1998). Preoperative CYFRA 21-1 level as a prognostic indicator in resected nonsmall cell lung cancer. European Respiratory Journal. 12(6). 1424–1428. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yan Zhu Breakdown of academic impact, for papers by David H. Moore Breakdown of academic impact, for papers by Krzysztof Goryca Breakdown of academic impact, for papers by J.M. Foidart Breakdown of academic impact, for papers by Wenting Xu Breakdown of academic impact, for papers by Ke Li Breakdown of academic impact, for papers by Valentina Pozzi Breakdown of academic impact, for papers by Chunxiang Li Breakdown of academic impact, for papers by Lijing Wang
Rankless by CCL
2026